Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.

José R Fiore, Fabio Zoboli, Mariantonietta Di Stefano, Giuseppina Faleo, Massimo Fasano, Teresa A Santantonio

Journal: AIDS (London, England) 2016;30(7):1144-6

PMID: 27028146

Abstract

Address: Department of Clinical and Experimental Medicine, Clinic of Infectious Diseases, University of Foggia, Foggia, Italy.

Medical:

Other Literature Sources:

Full Text Sources:

MeSH Terms: Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, HIV Infections, Humans, Male, Raltegravir Potassium, Semen, Treatment Outcome, Virus Shedding